JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB284402

COVID-19 S-Protein (S1RBD) ELISA Kit

COVID-19 S-Protein (S1RBD) ELISA Kit

Be the first to review this product! Submit a review

|

(5 Publications)

COVID-19 S-Protein (S1RBD) ELISA Kit is a Sandwich (quantitative) ELISA for the measurement of COVID-19 S-Protein (S1RBD) in in Cell Culture Media, Biofluids samples.

別名を表示する

2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein

1 Images
ELISA - COVID-19 S-Protein (S1RBD) ELISA Kit (AB284402)
  • ELISA

Supplier Data

ELISA - COVID-19 S-Protein (S1RBD) ELISA Kit (AB284402)

COVID-19 S-Protein (S1RBD) Standard Curve.

This standard curve is for demonstration only. A standard curve must be run with each assay.

Key facts

検出方法

Colorimetric

サンプルタイプ

Cell culture supernatant, Serum

アッセイタイプ

Sandwich (quantitative)

検出感度

= 4.5 pg/mL

検出範囲

6.14 - 1500 pg/mL

アッセイプラットフォーム

Pre-coated microplate (12 x 8 well strips)

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "sELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

製品の詳細

The COVID-19 S-Protein (S1RBD) ELISA Kit (ab284402) is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of COVID-19 S-Protein (S1RBD) in serum (plasma is not recommended in this assay) and cell culture supernatants. This assay employs an antibody specific for COVID-19 S-Protein (S1RBD) coated on a 96-well plate. Standards and samples are pipetted into the wells and COVID-19 S-Protein (S1RBD) present in a sample is bound to the wells by the immobilized antibody. The wells are washed and biotinylated anti-COVID-19 S-Protein (S1RBD) antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of COVID-19 S-Protein (S1RBD) bound. The Stop Solution changes the color from blue to yellow, and the intensity of the color is measured at 450 nm.

精度

[ { "reproducibilityType": "Intra", "sample": "Overall", "replicates": 0, "mean": null, "standardDeviation": null, "coefficientOfVariability": "< 10" }, { "reproducibilityType": "Inter", "sample": "Overall", "replicates": 0, "mean": null, "standardDeviation": null, "coefficientOfVariability": "< 12" } ]

回収率

[ { "sample": "Serum", "range": "94 - 117 %", "average": "= 104.6" }, { "sample": "Cell culture media", "range": "91 - 113 %", "average": "= 105.3" } ]

製品内容

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab284402-1x96Tests", "assetComponentDetails": [ { "size":"1 x 25 mL", "name":"20X Wash Buffer", "number":"AB284402-CMP02", "productcode":"" }, { "size":"1 x 8 mL", "name":"Stop Solution", "number":"AB284402-CMP07", "productcode":"" }, { "size":"1 x 1 Unit", "name":"Microplate", "number":"AB284402-CMP05", "productcode":"" }, { "size":"1 x 200 µL", "name":"HRP-Streptavidin Concentrate", "number":"AB284402-CMP01", "productcode":"" }, { "size":"1 x 30 mL", "name":"Assay Diluent A", "number":"AB284402-CMP03", "productcode":"" }, { "size":"1 x 12 mL", "name":"TMB One-Step Substrate Reagent", "number":"AB284402-CMP08", "productcode":"" }, { "size":"2 x 1 Vial", "name":"Detection antibody", "number":"AB284402-CMP09", "productcode":"" }, { "size":"1 x 15 mL", "name":"5X Assay Diluent B", "number":"AB284402-CMP04", "productcode":"" }, { "size":"2 x 1 Vial", "name":"Standard Protein", "number":"AB284402-CMP06", "productcode":"" } ] } } }

出荷温度及び保存条件

出荷温度
Blue Ice
短期保存温度
-20°C
長期保存温度
-20°C
保管に関する情報
-20°C

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The COVID-19 Spike Protein often referred to as SARS-CoV-2 Spike Protein is an important structural protein of the virus with a molecular mass around 180 kDa. This protein facilitates viral entry into host cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor which is primarily expressed in the respiratory tract. It's a trimeric protein composed of S1 and S2 subunits. The S1 subunit contains the receptor binding domain while the S2 subunit mediates membrane fusion.
Biological function summary

The spike protein plays an important role in viral infectivity and host range determination. The spike protein is part of the larger viral particle complex that includes other structural proteins like the nucleocapsid protein. Its interaction with host cell receptors triggers conformational changes allowing viral entry and subsequent replication within the host cells. This process is pivotal for the virus's lifecycle.

Pathways

The spike protein is integral to the viral entry pathway a critical step in the viral lifecycle. It intersects with the renin-angiotensin system (RAS) pathway through its interaction with the ACE2 receptor. This interaction not only facilitates viral entry but can also dysregulate the RAS pathway. Additionally the spike protein's activity is related to other viral proteins that assist in replication and assembly such as the envelope protein.

The spike protein is directly linked to COVID-19 the disease caused by SARS-CoV-2 infection. Its interaction with the ACE2 receptor has been associated with severe respiratory illnesses and potentially other conditions like cardiovascular disorders due to its effect on the RAS pathway. The nucleocapsid protein is also important in the virus's pathogenesis working together with the spike protein to establish infection and disease progression.

製品プロトコール

ターゲットの情報

Spike protein S1. Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. The major receptor is host ACE2 (PubMed : 32142651, PubMed : 32155444, PubMed : 33607086). When S2/S2' has been cleaved, binding to the receptor triggers direct fusion at the cell membrane (PubMed : 34561887). When S2/S2' has not been cleaved, binding to the receptor results in internalization of the virus by endocytosis leading to fusion of the virion membrane with the host endosomal membrane (PubMed : 32075877, PubMed : 32221306). Alternatively, may use NRP1/NRP2 (PubMed : 33082294, PubMed : 33082293) and integrin as entry receptors (PubMed : 35150743). The use of NRP1/NRP2 receptors may explain the tropism of the virus in human olfactory epithelial cells, which express these molecules at high levels but ACE2 at low levels (PubMed : 33082293). The stalk domain of S contains three hinges, giving the head unexpected orientational freedom (PubMed : 32817270).. Spike protein S2. Precursor of the fusion protein processed in the biosynthesis of the S protein and the formation of virus particle. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains two viral fusion peptides that are unmasked after cleavage. The S2/S2' cleavage occurs during virus entry at the cell membrane by host TMPRSS2 (PubMed : 32142651) or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change leading to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.. Spike protein S2'. Subunit of the fusion protein that is processed upon entry into the host cell. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains a viral fusion peptide that is unmasked after S2 cleavage. This cleavage can occur at the cell membrane by host TMPRSS2 or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change that leads to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.
See full target information S

文献 (5)

Recent publications for all applications. Explore the full list and refine your search

EBioMedicine 96:104800 PubMed37734205

2023

Biodistribution of mRNA COVID-19 vaccines in human breast milk.

Applications

Unspecified application

Species

Unspecified reactive species

Nazeeh Hanna,Claudia Manzano De Mejia,Ari Heffes-Doon,Xinhua Lin,Bishoy Botros,Ellen Gurzenda,Christie Clauss-Pascarelli,Amrita Nayak

Frontiers in immunology 14:1107156 PubMed37006315

2023

Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Anaïs Thiriard,Benjamin Meyer,Christiane S Eberhardt,Natasha Loevy,Serge Grazioli,Wafae Adouan,Paola Fontannaz,Fabienne Marechal,Arnaud G L'Huillier,Claire-Anne Siegrist,Daphnée Georges,Antonella Putignano,Arnaud Marchant,Arnaud M Didierlaurent,Geraldine Blanchard-Rohner

Cell reports. Medicine 3:100843 PubMed36480934

2022

A genetically engineered, stem-cell-derived cellular vaccine.

Applications

Unspecified application

Species

Unspecified reactive species

Amanda Cooper,Adam Sidaway,Abishek Chandrashekar,Elizabeth Latta,Krishnendu Chakraborty,Jingyou Yu,Katherine McMahan,Victoria Giffin,Cordelia Manickam,Kyle Kroll,Matthew Mosher,R Keith Reeves,Rihab Gam,Elisa Arthofer,Modassir Choudhry,Tom Henley,Dan H Barouch

Scientific reports 12:20923 PubMed36463322

2022

Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant.

Applications

Unspecified application

Species

Unspecified reactive species

Hiroki Hayashi,Jiao Sun,Yuka Yanagida,Takako Otera,Miwa Sasai,Chin Yang Chang,Jiayu A Tai,Tomoyuki Nishikawa,Kunihiko Yamashita,Naoki Sakaguchi,Shota Yoshida,Satoshi Baba,Munehisa Shimamura,Sachiko Okamoto,Yasunori Amaishi,Hideto Chono,Junichi Mineno,Hiromi Rakugi,Ryuichi Morishita,Masahiro Yamamoto,Hironori Nakagami

Nature medicine 28:1050-1062 PubMed35177862

2022

Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Keith Sacco,Riccardo Castagnoli,Svetlana Vakkilainen,Can Liu,Ottavia M Delmonte,Cihan Oguz,Ian M Kaplan,Sara Alehashemi,Peter D Burbelo,Farzana Bhuyan,Adriana A de Jesus,Kerry Dobbs,Lindsey B Rosen,Aristine Cheng,Elana Shaw,Mikko S Vakkilainen,Francesca Pala,Justin Lack,Yu Zhang,Danielle L Fink,Vasileios Oikonomou,Andrew L Snow,Clifton L Dalgard,Jinguo Chen,Brian A Sellers,Gina A Montealegre Sanchez,Karyl Barron,Emma Rey-Jurado,Cecilia Vial,Maria Cecilia Poli,Amelia Licari,Daniela Montagna,Gian Luigi Marseglia,Francesco Licciardi,Ugo Ramenghi,Valentina Discepolo,Andrea Lo Vecchio,Alfredo Guarino,Eli M Eisenstein,Luisa Imberti,Alessandra Sottini,Andrea Biondi,Sayonara Mató,Dana Gerstbacher,Meng Truong,Michael A Stack,Mary Magliocco,Marita Bosticardo,Tomoki Kawai,Jeffrey J Danielson,Tyler Hulett,Manor Askenazi,Shaohui Hu,Jeffrey I Cohen,Helen C Su,Douglas B Kuhns,Michail S Lionakis,Thomas M Snyder,Steven M Holland,Raphaela Goldbach-Mansky,John S Tsang,Luigi D Notarangelo
View all publications
websiteProtocolBooklet
en

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com